News

The development of health technology thrives thanks to cooperation

Advanced implants, healthcare AI applications and brain imaging devices are created through cooperation between companies, researchers, doctors and patients.
Markus Mäkelä
'Artificial intelligence will enable the more precise selection of treatments based on factors such as the patient’s genome, and this will make treatments more effective.' Photo: Aleksi Poutanen

Markus Mäkelä, Executive in Residence:

I lead the Aalto Health Platform, which connects companies, healthcare providers and other actors of society with the more than 90 research groups in Aalto’s health and wellbeing sector.  The sector involves the development and design of technologies, processes and facilities which are, at times, very significant for human health. These include, for example, devices used for brain imaging, new implant materials for surgery, innovative hospital architecture, and research methods for neuroscience, a field of study at the Helsinki University of Technology and Aalto for more than 40 years. 

One of the most interesting innovations from recent years is a neurosurgical instrument developed by Surgify Medical; the instrument prevents damage to nerves and veins during operations. Aalto’s researchers developed this technology in cooperation with HUS and the world-famous neurosurgeon Juha Hernesniemi.  

In addition to developing technology, researchers also produce information that supports decision-making in organisations and throughout society. For example, industrial engineering and management researchers have been involved in planning the national social welfare and healthcare system.  

Artificial intelligence (AI) and machine learning, too, open up many opportunities for patient work. For example, the sometimes difficult diagnoses of rare diseases are sped up when computers are trained, using large amounts of data, to support doctors in decision-making.   

As the population ages, the costs of and needs for healthcare increase. We live longer and end up being ill for longer times. In the future, cost savings will be achieved as medical care is individualised. Artificial intelligence will enable the more precise selection of treatments based on factors such as the patient’s genome, and this will make treatments more effective. With AI, we can also identify patients that are susceptible to chronic diseases and then attempt to significantly reduce the incidence of such diseases through lifestyle changes. Here at Aalto, our AI expertise, which is among the best in Europe, is integrated with biomedical research and applications. 

I represent Aalto in the Health Capital Helsinki alliance (HCH), which promotes business in the life sciences and health technology sectors. We initially established the alliance together with HUS, the University of Helsinki and the City of Helsinki. Now it also includes the Laurea, Metropolia and Haaga-Helia universities of applied sciences and the City of Espoo. Numerous companies have participated in the alliance’s various projects.   

HCH brings together companies, public administration and research institutes within the metropolitan area. One aim is also to attain increasing involvement from large foreign companies. Entrepreneurs benefit from services provided by, for example, the health-accelerator track of the HCH organisations: Spark Finland and Biodesign Finland, both brought from Stanford University, and Terkko Health X.

From clean energy to personalized medicine – a new book about the power of the university

The Aalto Effect is a tribute to the ambitious and uncompromising work of dozens of researchers.

Read more
Aalto Effect book cover / Photo by Mikko Raskinen
  • Published:
  • Updated:
Share
URL copied!

Related news

The BScBA Program alumna Tuuli Hakkarainen
Cooperation, Studies Published:

School of Business alumni story: Tuuli Hakkarainen

Unlike most of her fellow students, School of Business, Mikkeli Campus alumna Tuuli Hakkarainen chose an academic career path. She defended her dissertation in December 2020, and in her doctoral thesis she examined expertise sharing within multinational corporations.
Taiteellinen kuva panssaroidusta superhydrofobisesta pinnasta, joka kestää iskuja ja hylkii nesteitä tehokkaasti. Kuva: Juha Juvonen.
Cooperation, Press releases, Research & Art Published:

New funding to commercialise high-tech liquid-repelling coatings

New funding to get damage-resistant, liquid-repelling surfaces out of the laboratory and onto solar panels, skis, and more
BScBA Program alumni Elina Lamponen
Cooperation, Studies Published:

School of Business alumni story: Elina Lamponen

School of Business, Mikkeli Campus alumna Elina Lamponen gives current students a valuable piece of advice regarding working during studies: “Try to get a job at a smaller company. The company might not seem as prestigious as bigger companies, but the duties are usually more varied, and you get to see and do more and get responsibility early on.”
Kauppakorkeakoulun alumni Tiina Palmunen
Cooperation Published:

School of Business alumni story: Tiina Palmunen

Our alumna Tiina Palmunen became interested in Kesko’s trainee program when she met with an HR representative of that company at Aalto Summer Job Day. At her current position as HR Specialist at Employee Responsibility at Kesko, she works with diversity and inclusion matters.